Lung Health Articles & Analysis
21 news found
In the realm of pulmonary research, the search to understand complex lung conditions has led to the development of various animal models. Among these, a new murine model from Tsijis et al stands out for its potential to investigate flow-induced pulmonary hypertension (PH) and compensatory lung growth (CLG). This blog outlines this innovative model, its significance, and the method of ...
Founded in 1963, in Maids Moreton, Vitalograph’s mission has remained unwavering over the past six decades – to improve the lives of people living with lung conditions through the development and manufacture of respiratory diagnostic solutions. ...
With more than 60 years’ expertise in respiratory diagnostics, Vitalograph is the only company in the world specialized in delivering clinical trial services exclusively for pulmonary function-focused studies. Speaking about the recent additions to their portfolio of services, Richard James, Executive Vice President and Chief Operating Officer of Vitalograph Clinical Trials says: ...
(“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. ...
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, has onboarded more than 1,000 sites globally in its VIDA network of imaging sites. ...
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence data, is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials. ...
In early April 2022, VIDA received market authorization in Japan for its VIDA Insights software, which is a complementary data-driven solution used by lung care teams at the point of care, aiding them to detect disease early, diagnose with more confidence, make more personalized treatment decisions and use precision lung intelligence to better manage population ...
“I am pleased that VIDA has obtained market authorization in Japan, where lung disease is a major and growing health crisis,” said Yasutaka Nakano, MD, PhD Professor and Chairman, Division of Respiratory Medicine, Shiga University of Medical Science. ...
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has updated the entire EasyOne® product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019. Spirometry is ...
Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma (“Nuance”), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening ...
ByAerogen
VIDA and its comprehensive, lung intelligence solutions continue to gain traction among integrated delivery network (IDN) health care providers across the country. The agreement provides OSF HealthCare, an integrated Catholic health system with 14 hospitals, access to VIDA’s suite of lung health ...
He has authored or co-authored 11 patents on therapeutic interventions for lung and liver. Dr. Hogaboam has received financial research support from the National Institutes of Health, American Lung Association, Canadian Institutes of Health Research, and several Industry sponsors. He is frequently invited to speak at national ...
“Nearly three out of four potential clients that have evaluated SWORD Health against the competition have chosen our solution,” said Virgilio Bento, CEO of SWORD Health. ...
A ground-breaking development in the detection of reduced lung function, as seen in COVID-19 patients, is saving lives, time, and resources. ...
(“VIDA”), the leader in lung and respiratory intelligence, announced today that it is has appointed Karen Drexler to its board of directors, further expanding the company’s leadership strength in digital health technology. Drexler’s appointment comes at a critical time in healthcare, as the world continues to address the potential ...
Medicomp, Inc., a technology leader in remote and wireless cardiac monitoring, is pleased to announce a strategic partnership with New York based Lenox Hill Hospital, part of the Northwell Health system. Located in the epicenter of the US coronavirus pandemic, Lenox Hill Hospital will be using Medicomp’s TelePatch™ mobile cardiac telemetry (MCT) monitor to measure the ...
As of 2014, the most recent year that the Centers for Disease Control and Prevention (CDC) has lung cancer figures, more than 215,000 people nationwide were diagnosed with lung cancer. ...
May is Asthma Awareness Month, and the National Institutes of Health emphasizes the scientific progress being made in asthma research, from basic science, such as how lung cells work, to clinical trials on current and future treatments for the disease. ...
Program References/Resources: General Asthma Information: http://www.epa.gov/asthma/index.html EPA Asma en Espanol: www.epa.gov/iaq/espanol/asma.html National Asthma Awareness Month: http://www.epa.gov/asthma/awareness.html Children’s Asthma Campaign - Fight Asthma, Learn More campaign: http://noattacks.org/ Student Curriculum: Recipes for Healthy Kids and a Healthy Environment: ...
Exposure to air pollution from vehicles has been linked to increased mortality, cancer, lung ailments, and other health problems. Limited options to walk or bike have been shown to be a factor in obesity cases, which have reached epidemic proportions in the United States. ...